Thyroid Disease in Pregnancy

Clinics in Perinatology

Volumn 34, Issue 4, 2007, Pages 543-557

  Neale, Donna M ^a   Cootauco, Alice Chung ^a   Burrow, Gerard ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Mystic Aquarium and Institute for Exploration   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; DEXAMETHASONE; ESMOLOL; IMMUNOGLOBULIN; IODINE; IODINE 131; PHENOBARBITAL; POTASSIUM IODIDE; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE; THIONAMIDE DERIVATIVE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADAPTATION; AGITATION; AGRANULOCYTOSIS; BINDING AFFINITY; BRADYCARDIA; BRONCHOSPASM; CHOANA ATRESIA; DEFORMITY; DRUG FEVER; EMBRYOPATHY; ESOPHAGUS FISTULA; FACE MALFORMATION; FETUS DEVELOPMENT; FETUS DISEASE; GESTATION PERIOD; GRAVES DISEASE; HEPATITIS; HUMAN; HYPERTHYROIDISM; HYPOGLYCEMIA; HYPOTHYROXINEMIA; INTRAUTERINE GROWTH RETARDATION; LUPUS LIKE SYNDROME; ORGANOGENESIS; PERINATAL PERIOD; PHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PROTEIN BINDING; PRURITUS; RASH; REVIEW; SKIN APLASIA; THYROID CANCER; THYROID DISEASE; THYROID FUNCTION; THYROID GLAND; THYROID HORMONE RELEASE; THYROIDECTOMY; THYROIDITIS; THYROTOXICOSIS;

ADAPTATION, PHYSIOLOGICAL; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS; THYROID DISEASES; THYROID GLAND;

EID: 36549038061     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2007.10.003     Document Type: Review

References (51)

1. American Academy of Clinical Endocrinologists Jan 2004 press release. (2004 Thyroid Awareness Campaign Encourages Patients and Physicians to Take Control of Thyroid Health).
2. De Benoist B, Delange F, Hill ID 2006 Prevention and control of iodine deficiency in pregnant and lactating women and in children less than two years old: Conclusions and recommendations. Public Health Nutrition (in press).
3. Surks M.I., Oritz E., Daniels G.H., et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291 2 (2004) 228-238
4. Greenberg F. Choanal atresia and athelia: methimazole teratogenicity or a new syndrome?. Am J Med Genet 28 4 (1987) 931-934
5. Casey B.M., and Leveno K.J. Thyroid disease in pregnancy. Obstet Gynecol 108 5 (2006) 1283-1292
6. Wartofsky L., and Dicky R.A. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 90 9 (2005) 5483-5488
7. Casey B.M., Dashe J.S., Wells E., et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 105 2 (2005) 239-245
8. Canaris G.J., Manowitz Mayor G., and Ridgway E.C. The Colorado thyroid disease prevalence study. Arch Intern Med 160 (2000) 526-534
9. Casey B.M., Dashe J.S., Spong C.Y., et al. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol 109 5 (2007) 1129-1135
10. Brent G.A. The molecular basis of thyroid hormone action. N Engl J Med 331 (1994) 847-853
11. Brennan M.D., and Bahn R.S. Thyroid hormone and illness. Endocr Pract 4 (1998) 396
12. Burrow G.N., Fischer D.A., and Larsen P.R. Maternal and fetal thyroid function. N Engl J Med 331 (1994) 1072-1078
13. Grun J.P., Meuris S., DeNayer P., et al. The thyrotrophic role of human chorionic gonadotropin (hCG) in the early stage of twin (versus single) pregnancy. Clin Endocrinol 46 (1997) 719-725
14. Ferris T.F. Renal disease. In: Burrow G.N., and Ferris T.F. (Eds). Medical complications during pregnancy (1988), WB Saunders, Philadelphia
15. Rasmussen N.G., Hornnes P.J., and Hegedus L. Ultrasonographically determined thyroid size in pregnancy and post partum: the goitrogenic effect of pregnancy. Am J Obstet Gynecol 160 (1989) 1216-1220
16. Glinoer D., and Derange F. The potential repercussions of maternal, fetal and neonatal hypothyroxinemia on the progeny. Thyroid 10 (2000) 871-887
17. Thorpe-Beeston J.G., Nicolaides K.H., Felton C.V., Butler J., et al. Maturation of the secretion of thyroid hormone and thyroid stimulating hormone in the fetus. N Engl J Med 324 (1991) 532-536
18. Vulsma T., Gons M.H., and deVijlder J.J. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to total organification defect or thyroid agenesis. N Engl J Med 321 (1989) 13
19. Eeker J.L., and Musci T.J. Thyroid function and disease in pregnancy. Curr Probl Obstet Gynecol Fertil 23 (2000) 109-122
20. Davis L.E., Lucas M.J., Hawkins G.D., et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160 (1989) 63-70
21. Weetman A.P. Graves disease. N Engl J Med 343 (2000) 1236-1248
22. Goodwin T.M., Montoro M., and Mestman J.H. Transient hyperthyroidism and hyperemesis gravidarum: Clinical aspects. Am J Obstet Gynecol 167 (1992) 648-652
23. Glinoer D., DeNayer P., Robyn C., et al. Serum levels of intact human chorionic gonadotropin (hCG) and its free α and β subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest 16 (1993) 881-888
24. Mandel S.J., and Cooper D.S. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 86 (2001) 2354-2359
25. Cooper D.S., Goldminz D., Levin A.D., et al. Agranulocytosis associated with antithyroid drugs. Ann Intern Med 98 (1983) 26-29
26. Van Dijke U.P., Heydendael R.J., De Kleine M.J., et al. Methisazole, carbimazole and congenital skin defects. Ann Intern Med 106 (1987) 60-61
27. Mortimer R.H., Cannell G.R., and Addison R.S. Methisazole and propylthiouracil equally cover the perfused human term placental lobule. J Clin Endocrinol Metab 82 (1997) 3099-3102
28. DiGianantonio E., Schaefer C., Mastrioacovo P.P., et al. Adverse effects of premature methisazone exposure. Teratology 64 (2001) 262
29. Wing D.A., Millar L.K., Koonings P.P., et al. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 170 (1994) 90-95
30. Laurberg P., Nygaard B., Glinoer D., et al. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 139 (1998) 584-586
31. Matsuura N., Harada S., Ohyama Y., et al. The mechanisms of transient hypothyroidism in infants born to mothers with Graves' disease. Pediatr Res 42 (1997) 214-218
32. Gorman C.A. Radio iodine and pregnancy. Thyroid 9 (1999) 721-726
33. Molitch M.E. Endocrine emergencies in pregnancy. Baillieres Clin Endocrinol Metab 6 (1992) 167-191
34. Klein R.Z., Haddow J.E., and Faix J.D. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol 35 (1991) 41-48
35. Haddow J.E., Palomaki G.E., Allan W.C., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341 (1999) 549-555
36. Alvarez-Marfany M., Roman S.H., Drexler A.J., et al. Long term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 79 (1994) 10-16
37. Glinoer D. Pregnancy and iodine. Thyroid 11 (2001) 471-481
38. Weetman A.P., and McGregor A.M. Autoimmune thyroid disease: further development is an understanding. Endocrinol Rev 15 (1994) 788-830
39. Werner S. Modification of the classification of eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 44 (1977) 203-204
40. Stagnaro-Green A.S. Recognizing, understanding and treating postpartum thyroiditis. Endocrinol Metab Clinics NA 29 (2000) 417-430
41. Tachi J., Amino N., Tamaski M., et al. Long term follow-up and HLA association in patients with postpartum hypothyroidism. J Clin Endocrinol Metab 66 (1988) 480-484
42. Lucas A., Pizarro E., Granada M.L., et al. Postpartum thyroiditis: epidemiology and clinical evolution in a non selected population. Thyroid 10 (2000) 71-77
43. Pop V.S.M., de Rooy H.A.M., Vader H.L., et al. Postpartum thyroid dysfunction and depression in an unselected population. N Engl J Med 324 (1991) 1815-1816
44. Harris B., Fong M., Johns S., et al. Transient postpartum thyroid dysfunction and postnatal depression. J Affect Disord 17 (1989) 243
45. Harris B., Othman S., Davies J.A., et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ 305 (1992) 152-156
46. Pop V.S.M., deVries E., van Baar A.L., et al. Microsomal antibodies during gestation in relation to postpartum thyroid dysfunction and depression. Acta Endocrinol 129 (1993) 26-30
47. Janssen R., Dahlberg P.A., Winsa B., et al. The postpartum period constitutes an Important risk for development of clinical Graves' disease in young women. Acta Endocrinol 116 (1987) 321-325
48. Davies T.F. The thyroid immunology of the postpartum period. Thyroid 9 (1999) 675-684
49. Balan K.K., and Critchley M. Outcome of pregnancy following treatment of well differentiated thyroid cancer with 131 Iodine. Br J Obstet Gynec 99 (1992) 1021-1024
50. AACE Thyroid Task Force. American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8 (2002) 457-469
51. American College of Obstetricians and Gynecologists. Thyroid disease in pregnancy. Clinical management guidelines for obstetrician-gynecologists. ACOG Practice Bulletin No. 37. Obstet Gynecol 100 (2002) 387-396